Philip R Greipp

Title: Biography of Philip R Greipp

Introduction

Philip R Greipp is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the area of myeloma prognosis and DNA detection.

Latest Patents

Greipp holds two patents, with his latest inventions focusing on critical advancements in medical diagnostics. The first patent, titled "Cytogenetically determined prognosis of myeloma," provides methods and materials for determining a prognosis for myeloma and myeloma-disposed patients. This invention utilizes FISH techniques to identify chromosomal abnormalities that indicate a poor prognosis. The second patent, "Detection of cellular DNA," describes a method for detecting halodeoxyuridines taken up by cells during DNA synthesis using monoclonal antibodies. This method also allows for the simultaneous detection of cell surface receptors.

Career Highlights

Throughout his career, Greipp has worked with prominent organizations, including Becton Dickinson and Company Limited and the Mayo Foundation for Medical Education and Research. His work has significantly impacted the field of medical diagnostics and treatment.

Collaborations

Greipp has collaborated with esteemed colleagues, including Elizabeth L Evans and Nick J Gonchoroff. These collaborations have furthered his research and contributed to the advancements in his field.

Conclusion

Philip R Greipp's innovative work and patents have made a lasting impact